Search For Lab Tests Here

The Insulin Response to Glucose Test, 5 Specimens evaluates insulin secretion at fasting and multiple post-glucose solution intervals. This expanded assessment highlights beta-cell function, insulin sensitivity, and abnormalities in carbohydrate metabolism. Results offer valuable information on how the body clears glucose and help identify insulin resistance, metabolic dysfunction, and diabetes-related risks.

The Insulin Response to Glucose Test, 6 Specimens evaluates insulin secretion and glucose regulation with fasting and five post-glucose solution samples. This comprehensive approach highlights beta-cell activity, insulin resistance, and abnormalities in carbohydrate metabolism. Results show how efficiently the body clears glucose, supporting early detection of metabolic dysfunction, prediabetes, and diabetes risk.

The Insulin Response to Glucose Test, 3 Specimens evaluates insulin secretion at three time points: fasting and after drinking a glucose solution at set intervals. This approach helps identify abnormal insulin sensitivity, altered beta-cell activity, and impaired carbohydrate metabolism. Results provide essential information about how efficiently the body regulates glucose, supporting early detection of insulin resistance or diabetes risk.

The Insulin Response to Glucose Test, 2 Specimens evaluates insulin secretion by comparing fasting levels with those measured after drinking a glucose solution. This test helps identify impaired insulin sensitivity, abnormal glucose regulation, and early metabolic dysfunction. It provides valuable information on beta-cell function, carbohydrate metabolism, and risk of developing prediabetes or diabetes.

The Insulin Response to Glucose Test, 4 Specimens evaluates insulin secretion and glucose regulation using fasting and three post-glucose solution samples. This expanded view highlights beta-cell activity, insulin resistance, and abnormal carbohydrate metabolism. Results reveal how efficiently the body processes glucose and help identify metabolic dysfunction, prediabetes, and diabetes-related risks.

The Insulin Response to Glucose Test, 7 Specimens evaluates insulin secretion and glucose regulation using fasting plus six post-glucose solution samples. With seven data points, the test highlights abnormalities in beta-cell activity, insulin resistance, and carbohydrate metabolism. Results provide valuable insight into how the body processes glucose and help identify metabolic dysfunction, prediabetes, or diabetes risk.

The Insulin Response to Glucose Test, 8 Specimens evaluates insulin secretion and glucose handling using fasting and seven post-glucose solution samples. This extended assessment highlights beta-cell activity, insulin resistance, and carbohydrate metabolism. Results reveal how efficiently the body processes glucose, supporting early detection of prediabetes, diabetes, or related metabolic disorders.

The Insulin Response to Glucose Test, 9 Specimens evaluates insulin secretion and glucose regulation through fasting plus eight post-glucose solution samples. This extended assessment highlights beta-cell performance, insulin resistance, and carbohydrate metabolism. Results provide insight into how the body processes glucose and support early detection of metabolic dysfunction, prediabetes, or diabetes risk.

The Advanced Blood Sugar Monitoring - Basic Plus panel offers a more detailed look into blood sugar regulation and potential autoimmune aspects of diabetes. It includes the 3 Specimens Glucose Tolerance Test, Glutamic Acid Decarboxylase-65 Antibody, Hemoglobin A1c, and 3 Specimens Insulin Response to Glucose, providing a comprehensive evaluation of glucose metabolism and insulin function.

The Advanced Blood Sugar Monitoring - Advanced panel provides an in-depth analysis of blood sugar regulation, insulin function, and potential autoimmune aspects of diabetes. This comprehensive panel includes Adiponectin, a 4 Specimens Glucose Tolerance Test, Glutamic Acid Decarboxylase-65 Antibody, Hemoglobin A1c, and a 4 Specimens Insulin Response to Glucose test.

The Advanced Blood Sugar Monitoring - Comprehensive panel is the most extensive assessment in the series, designed to provide a detailed analysis of glucose metabolism, insulin sensitivity, and autoimmune diabetes indicators. It includes Adiponectin, a 5 Specimens Glucose Tolerance Test, Glutamic Acid Decarboxylase-65 Antibody, Hemoglobin A1c, IA-2 Antibody, a 4 Specimens Insulin Response to Glucose, and Proinsulin tests.

 The DH-4 Diabetes Health panel is a comprehensive suite of tests tailored for individuals with diabetes, particularly those with complex management needs or those at high risk for complications. This panel includes C-Reactive Protein (CRP), CBC with Differential and Platelets, Comprehensive Metabolic Panel (CMP), 2 Specimen Glucose Tolerance Test, Hemoglobin A1c, Insulin, 2 Specimen Insulin Response to Glucose, Lipid Panel, and Random Urine Microalbumin with Creatinine. It is designed to provide a thorough assessment of diabetes control, cardiovascular risk, insulin function, kidney health, and overall metabolic status.

The C-Peptide Response to Glucose Test with 5 specimens measures pancreatic beta cell activity and insulin secretion across five timed intervals. Tracking C-peptide levels over multiple points provides detailed insight into glucose regulation, insulin resistance, hypoglycemia, and diabetes risk, supporting evaluation of metabolic balance and overall endocrine health.

The C-Peptide Response to Glucose Test with 2 specimens evaluates pancreatic beta cell activity and insulin secretion during glucose intake. By measuring changes in C-peptide levels at two time points, it helps assess insulin production, glucose regulation, and potential insulin resistance or diabetes-related disorders. This test offers insight into metabolic health and endocrine function.

The Advanced Blood Sugar Monitoring - Basic panel is designed to provide fundamental insights into an individual's glucose metabolism and overall blood sugar control. This panel includes two essential tests: Glucose and Hemoglobin A1c, making it an invaluable tool for initial diabetes screening and monitoring.

The Glucagon Test evaluates hormone levels that regulate glucose by stimulating the liver to release stored sugar. Elevated or low glucagon may indicate diabetes, hypoglycemia, metabolic disorders, or pancreatic disease. This test provides insight into endocrine activity, glucose balance, and systemic health conditions related to energy metabolism and hormonal function.

 The DH-1 Diabetes Health panel is specifically curated to provide a foundational assessment of an individual's diabetes status and metabolic health. It includes two essential tests: the Comprehensive Metabolic Panel (CMP) and the Hemoglobin A1c (HbA1c). This panel is designed to give a snapshot of the current glucose control and the body's metabolic state, offering crucial insights for managing diabetes effectively.

 The Diabetes Prevention Program (DPP) Screening Panel is a critical tool in the early identification and management of prediabetes and diabetes. This panel utilizes targeted tests to evaluate an individual's blood sugar levels and their body's ability to process glucose over time. By accurately assessing these factors, the panel helps healthcare providers detect early signs of glycemic control issues, enabling timely intervention that can prevent the onset of diabetes or manage it effectively in its initial stages.

The C-Peptide Test measures C-peptide levels in blood to assess insulin production and pancreatic function. Low levels may indicate type 1 diabetes or reduced insulin production, while high levels may suggest type 2 diabetes, insulin resistance, or insulinoma. Doctors use this test to differentiate diabetes types, monitor treatment, and evaluate unexplained hypoglycemia. It provides key insight into endocrine, pancreatic, and metabolic health.

 The Hormone Health, Women - Basic Panel is meticulously curated to address the unique hormonal landscape of women, focusing on the pivotal hormones that significantly influence a woman’s reproductive health, metabolic function, and overall well-being. This fundamental diagnostic ensemble is essential for delving into the intricate interplay of hormones that regulate critical physiological processes, from menstrual cycles and fertility to stress responses and thyroid functionality.

The Atherosclerotic Risk Screening Panel evaluates key cardiovascular risk markers including cholesterol, blood sugar control, metabolic function, and inflammation. By combining a Lipid Panel, Hemoglobin A1c, Comprehensive Metabolic Panel, and hs-CRP, this comprehensive assessment helps identify factors linked to arterial plaque development and long-term heart health.

The Cardio IQ™ ApoE Genotype Test analyzes apolipoprotein E (ApoE) gene variants linked to cholesterol metabolism and cardiovascular risk. Results help assess risk for heart disease, hyperlipidemia, and Alzheimer’s disease. This genetic test guides personalized prevention and treatment strategies, including diet, lifestyle, and lipid-lowering therapies, supporting long-term cardiovascular and brain health.